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ABSTRACT 
 
The aim of our work was to estimate the maximum strength of the upper and lower limbs (quadriceps, 
gastrocnemius, biceps, triceps, deltoid) in a group of patients affected by various cardiovascular diseases 
and compare it with that of a group of healthy and sedentary subjects (n = 20). We also wanted to assess 
whether there were differences in the maximum strength between different groups of cardiovascular 
diseases. This study presents many innovative elements, primarily two ones: (a) to recognize the importance 
of muscle strength as a health component in heart patients; (b) to establish a method for the assessment of 
strength based on estimation of 1RM. Here are presented the patients recruited on the basis of the basic 
pathology: 45 patients had chronic heart failure (CHF) in clinical stability for at least 3 months, class NYHA 
II-III; 21 patients had peripheral obliterative arteriopathy with claudication (POAC, stage IIa of Fontaine); 22 
patients had undergone coronary angioplasty (coronary artery disease - CAD); 6 patients had undergone 
orthotopic cardiac transplant (HT) for at least 6 months. Chronic cardiovascular patients are characterized 
by a muscular impairment that parallels the history of the disease. Key words: Cardiovascular disease; 
Strength; Upper limb; Lower limb. 
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INTRODUCTION 
 
Muscular strength is a fundamental component of exercise and functional capacity, particularly in patients 
with chronic disease. Muscular strength is positively related to independence, quality of life and ability to 
perform activities of daily living; and it play also a crucial role in reducing disability and in the prevention of 
chronic disease1,2. 
 
Patients diagnosed with chronic heart disease display diminished exercise tolerance. This can be attributed 
not only to a reduction in aerobic capacity, as has been amply demonstrated in the li terature3, but probably 
also to a strength deficit such as muscle structure alterations, including muscle weakness and volume 
reduction, and other pathophysiological mechanisms that underlie both aerobic and strength. The result is 
that exercise intolerance is a common clinical manifestation in cardiovascular patients4. 
 
Indeed, back in the early 1990s, Drexler demonstrated that patients diagnosed with chronic heart failure 
(CHF) exhibit a particular pattern of myopathy characterized by muscular atrophy and a shift in the distribution 
of fiber type with a reduced oxidative capacity5. The initial loss of type I fibers, which is responsible for 
endurance, is followed by a consecutive increase in type II fibers. While until not long ago three types o f 
muscle fibers were identified (I; IIa; IIb), currently fibers of the skeletal muscle are classified into four types 
according to their biochemical characters: (a) slow-twitch type I fatigue-resistant fibers; (b) fast-twitch type 
IIa fatigue-resistant fibers; (c) fast-twitch type IIx fibers with intermediate fatigue-resistance; (d) and fast-
twitch type IIb fatigable fibers6. 
 
Recently, Katsuki et al. (2015) demonstrated the activation of Wnt signalling inducted by C1q that seems 
contributes to fiber type shift toward fatigable fiber. So fiber type shift toward more fatigable type IIb fiber is 
one of the characteristics observed during the development of skeletal myopathy in cardiovascular patients7. 
 
 Besides all this, the story of illness leads the patient to a sedentary lifestyle then to atrophy and muscle 
weakness, and consequently to a "cascade" of events responsible for the diminished exercise tolerance and 
strength deficit. Strength decreases with the severity of disease for reasons that are in part explained (see 
above) and in part still unknown. 
 
Poor muscle strength is associated with mortality: persons with poorer baseline strength are more likely to 
die over a follow-up period of 30 years. Although the mechanism explaining the association between muscle 
strength and mortality risk remains to be explored, probably the risk of mortality is due to low levels of muscle 
mass8. 
 
Maximum strength of the quadriceps muscle in patients with CHF is an important prognostic index; indeed, 
in the opinion of some, it is superior to the VO2max9. Handgrip strength can predict long term mortality in 
patients with CHF10and 6-month mortality in population with coronary artery disease (CAD)11. Other studies 
found that muscle strength in men without heart disease was inversely and independently associated with 
all-cause mortality12,13. 
 
While muscular impairment in CHF patients has been amply studied, there are limited case-reports on the 
strength characteristics of patients affected by other cardiovascular pathologies, such as CAD without 
ventricular dysfunction. Less attention has been directed also to the issue of post heart transplant (HT) 
functional capacity14. 
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This study presents many novelty and innovative elements: (a) to recognize the importance of muscle 
strength as a health component in heart patients (not only the aerobic component as in the past); (b) to 
establish a method for the assessment of strength based on estimation of 1RM: (b1) allowing partial 
information on the severity and history of the disease, (b2) establishing a targeted rehabilitation program 
(based on % of 1RM), (b3) presenting a protocol that is replicable at any medical sports centre or gymnasium 
(with simple tools) not just for doing research but also for those who deal with clinical activity and physical 
training (being able to establish the baseline and to compare the various diseases on a cross sectional design 
as well as improvements of each patient in a longitudinal direction (other studies have not found who set out 
with the same goal as will be explained in the discussion stage)15,16. 
 
Taking into account all these premises, the aim of this study was therefore to estimate maximum dynamic 
strength of the upper and lower limbs (quadriceps, gastrocnemius, biceps, triceps, deltoid) in a group of 
patients affected by various cardiovascular diseases and compare it with that of a group of healthy and 
sedentary subjects (n = 20). We also wanted to assess whether there were differences in the maximum 
strength between different groups of cardiovascular diseases. 
 
METHODS 
 
Subjects involved 
Here are presented the patients recruited on the basis of the basic pathology: 45 patients (39 males and 6 
females) had chronic heart failure (CHF) in clinical stability for at least 3 months, class NYHA II-III; 21 patients 
(16 males and 5 females) had peripheral obliterative arteriopathy with claudication (POAC, stage IIa of 
Fontaine); 22 all male patients had undergone coronary angioplasty (coronary artery disease - CAD); 6 
patients (4 males and 2 females) had undergone orthotopic cardiac transplant (HT) for at least 6 months. 
 
Maximum strength estimate of the five muscles tested was significantly lower in patients diagnosed with heart 
disease compared to the control group. When patients were subdivided according to the type of disease, a 
clear trend among groups was displayed with maximum strength in lower limbs being higher in controls, 
followed by the CAD group, then CHF group, the HT group, and POAC group. In the upper limbs CAD was 
followed by POAC, while the order of the other groups remained unchanged. 
 
Strength evaluation 
The maximum strength of the quadriceps and the brachial biceps muscles was assessed by means of sub-
maximal tests. The tests were deemed appropriate when, for a given load, the subject was able to carry out 
10 or fewer repetitions of the movement before fatigue. Once the load and the number of repetitions valid for 
the test had been established, the following indirect formula was used to calculate the value of 1 repetition 
maximum (1 RM): Predicted 1 RM = Weight Lifted/1.0278-.0278X (where X is the number of reps performed) 
17. 
 
Therefore, predicted 1 RM refers to the maximum weight estimate a person can lift only once in a complete 
range of motion17. Maximum strength of each muscle was obtained through the normalization of 1 RM (kg) 
by body weight (kg) to avoid the influence of other variables such as muscle mass9. Average strength of the 
muscles of both right and left limbs was considered. During testing, the patient’s electrocardiogram was 
constantly monitored telemetrically. 
 
Strength testing, in which each exercise involves a contraction phase and a relaxation phase of 2 seconds, 
comprised. 
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Before the measurement began, the subjects were instructed to warm up for about 10 min (including 5 min 
of cycling and 5 min of mobility and free movements of the arms and legs). After warming up, the subjects 
were familiarized with the device by performing 8-10 repetitions at the lowest load, then the load was 
gradually increased until reaching the optimal load. All tests were performed by the same two technicians. 
Only moderate standardized verbal encouragement was given to all participants during the test. 
 
Statistical Analysis 
All data were processed using the SPSS 18.0 program. Age and anthropometric characteristics are 
expressed as mean value ± standard deviation. Comparisons between groups were analysed by unpaired t 
test (2-sided) or Analysis of variance (one-way ANOVA) for comparisons with >2 subgroups. Bonferroni post-
hoc multiple comparisons were performed when appropriate. The alpha-error probability was set at p<.05 (2-
sided). When examining the difference between two conditions, effect size was calculated using Cohen’s d. 
When variables were more than two, effect size was calculated using eta squared ( 2). 
 
RESULTS 
 
Group comparisons between patients overall and controls are shown in Figure 1 [±95% confidence interval]. 
Maximum strength of quadriceps muscles was significantly lower in patients (M=1.76; SD=.59) compared to 
the control group (M=2.46; SD=.62) with a difference of 31% (p=.0001; d=1.15). Maximum strength of brachial 
biceps muscle was significantly lower in patients (M=.19; SD=.03) compared to the control group (M=.13; 
SD=.03) with a difference of 32% (p<.0001; d=2.00). 
 
One-way ANOVA showed between-group differences in maximum strength of both quadriceps (F1,169=14.37, 
p=.0001) and brachial biceps (F1,169=27.21, p=.0001) muscles while there were no significant differences in 
maximum strength for the other muscles. 
 
When patients were subdivided according to the type of disease, although strength differences were not 
always significant, a clear trend among groups was displayed with maximum strength being higher in controls, 
followed by the POAC group, then the CAD group, the CHF group, and the HT group [±95% confidence 
interval]. The group of patients diagnosed with diabetes did not differ from other patients in maximum strength 
of both quadriceps (p = .06) and brachial biceps (p = .06) muscles respectively. 
 
DISCUSSION 
 
Cardiovascular rehabilitation is a well-established means of improving the functional capacity, physiological 
outcomes, quality of life and psychological well-being in patients with cardiovascular disease18-20. Resistance 
training is now recommended as a component of cardiac rehabilitation by the major guidelines1,2,19. As it 
happen in aerobic training, for a correct strength training prescription, it is necessary to be aware of the 
baseline status of the patients in order to develop a training program that effectively stresses peripheral 
muscles without creating cardiovascular overload. To our knowledge, no previous studies compared the 
baseline strength status in different types of chronic heart disease. Therefore, the purpose of the present 
study was to estimate maximum dynamic strength of the two primary antigravity muscles of upper and lower 
limbs in three categories of patients with chronic heart disease: POAC, CAD, CHF, and HT. 
 
Unlike most of the studies reported in the literature, which have utilized isokinetic testing, our study evaluated 
patients by means of a different technique. We decided to evaluate dynamic maximum strength estimating 1 
RM (using free weights and a machine) rather than assessing isokinetic force, work, and power or isometric 
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force1. Our decision was dictated by the need to utilize a test that would be both simple and reliable, and 
which would require inexpensive equipment that enabled us to identify the training work-load and to formulate 
strength training prescriptions to be implemented not only in hospital but also in local gymnasiums16. 
 
Note. *p<.001 
Figure 1. Maximum strength estimate of the patients enrolled compared with a control group (±95% 
confidence interval: mean ± 2 standard error of mean) 
 
Strength assessment revealed that the maximum strength of the heart disease patients was 28-32% less 
than that of a control group of age-matched healthy sedentary subjects (see Figure 1). This should come as 
no surprise since patients with chronic heart disease often experience impairment, functional limitation and 
disability due to deteriorating health. Since our patients expressed a great variability in type of disease, 
disease severity, and in the concurrence of other chronic conditions we decided to estimate maximum 
strength according to the type of heart disease. 
 
When the patients were subdivided according to the disease, it clearly emerged that the strongest patients 
with regard to both the muscle groups were those in the POAC group, followed by CAD group, the CHF 
group, and then the HT group. This is the logical consequence of the history of the disease. Indeed, patients 
who undergo angioplasty often come in for the procedure without having ever suffered from any symptoms 
that might prompt them to limit their physical effort, or else with symptoms of recent onset. Moreover, 
hospitalizations are usually very short. At any rate, although CAD group was found to be the strongest group 
in patient sample, maximum strength of the lower limbs was significantly lower (19%) than that of the control 
group. This finding seems to confirm the data of previous studies on strength in patients diagnosed with 
coronary disease: Ghroubi reported a 25% strength deficit in the lower limbs on isokinetic testing21 and Gayda 
a diminished resistance to isometric effort22. The small discrepancy between the studies may be accounted 
for by the differences in strength testing technique as well as the control group: while we enrolled age 
matched healthy sedentary subjects with no previous muscle strength training experience, the above 
mentioned studies compared the patients to a group of physically active age matched controls. 
 
The natural history of patients diagnosed with CHF is different: repeated hospitalizations together with the 
pivotal symptoms of heart failure, asthenia and effort dyspnea, prompt patients to limit themselves with regard 
not only to strenuous effort but also to moderate activity, even to the extent of impairing normal everyday 
actions in patients with longstanding disease. To this, we may add the effect of malnutrition, which 
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complicates the clinical picture in patients who are in the most advanced functional class23. So, the fact that 
this group of patients reported a strength deficit of about 31% compared to the control group, is not surprising. 
 
HT patients seem to be the weakest of all, even if data are not always significant owing to the small size of 
the sample and the variability in years of disease prior to the transplant. Nevertheless, HT is often an effective 
treatment option for patients with end-stage CHF. Most patients who undergo transplantation spend long 
periods in bed before the operation. Muscular weakness and fatigue are the primary limiting symptoms in the 
day to day activities of many of these patients. Moreover, the immunosuppressive and cortisone therapy 
required after transplantation weakens the muscles further. Back in the 1993, Braith et al. 24 estimated that 
the quadriceps muscle strength of patients with HT is 60-70% of that in age-matched controls. Our study 
seems to consolidate this data but with a lower estimate of the deficit in HT recipients (52%). 
 
Summarizing, the present study showed that chronic cardiovascular patients are characterized by a muscular 
impairment that parallels the history of the disease: baseline strength status decreases with the increase of 
the disease severity. 
 
To our knowledge, no previous studies measured maximum strength of small muscle groups in patients with 
chronic heart disease. The novelty of this study was not only to estimate the maximum strength of the 
quadriceps but also that of the brachial biceps in three categories of patients with chronic heart disease (CAD, 
CHF, and HT), which showed a similar trend of quadriceps muscle. 
 
IMPLICATIONS 
 
Resistance training is not only safe and practicable25 but it also plays a crucial role in cardiovascular 
rehabilitation setting. It has a lot of benefits such as enhancing muscular strength, functional capacity, 
independence, quality of life and reducing disability17. This study shows that patients with chronic heart 
disease have a strength impairment which parallels the history of disease. In our opinion this peripheral de-
conditioning requires a different approach in the rehabilitation setting. Different types of heart disease show 
a different trend of strength: it is therefore necessary to evaluate the strength baseline status to be able to 
train strength, identifying the most appropriate work-load. A strength training with lower loads for a more 
prolonged period of time seems advisable in the local gymnasium setting16. This lower intensity phase should 
yield an initial aerobic and strength reconditioning which is recommended before switching to higher intensity 
training26. 
 
LIMITATIONS 
 
This study presents other two limitations: a lack of data on body composition, and specifically on lean body 
mass; muscle biopsy was not performed to report on muscle physiology. 
 
CONCLUSIONS 
 
The maximum strength of both quadriceps and the brachial biceps muscles is significantly lower in patients 
diagnosed with chronic heart disease than in healthy control subjects. Moreover, it seems that chronic 
cardiovascular patients are characterized by a muscular impairment that parallels the history of the disease. 
This information should be kept in mind when planning a rehabilitation program. 
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